ALX ONCOLOGY HOLDINGS INC Accrued Liabilities and Other Liabilities
ALX ONCOLOGY HOLDINGS INC (ALXO) had Accrued Liabilities and Other Liabilities of $11.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities and Other Liabilities $11.75M.
- 2026-03-31: Accrued Liabilities and Other Liabilities $11.11M.
- 2025-12-31: Accrued Liabilities and Other Liabilities $14.42M.
- 2025-09-30: Accrued Liabilities and Other Liabilities $16.79M.
| Period end | Accrued Liabilities and Other Liabilities | Accrued Liabilities and Other Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $11.75M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $11.11M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $14.42M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $16.79M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $10.86M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $13.02M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $13.42M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $24.39M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $30.08M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $25.63M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $26.87M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $21.88M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $13.20M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $11.23M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $18.60M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $16.60M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $12.75M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $8.73M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $9.90M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $7.21M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $7.38M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.78M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $6.13M 10-K · filed 2022-02-28 | $6.20M 10-K · filed 2021-03-18 |
| 2020-09-30 | $3.21M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $4.14M 10-Q · filed 2020-08-27 | |
| 2019-12-31 | $1.24M 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |